PDCD1 and osteosarcoma: These cells heavily infiltrate the osteosarcoma TME, promoting cancer progression by inhibiting the proliferation of anti-cancer cytotoxic T cells (CTLs) and preventing CTL-associated anti-PD-1 cancer therapy [22].